These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9283512)

  • 21. Prospects for pharmacotherapy of schizophrenia.
    Pickar D
    Lancet; 1995 Mar; 345(8949):557-62. PubMed ID: 7539875
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of clozapine in schizophrenia; starting points for current pharmacotherapeutics].
    Kahn RS
    Ned Tijdschr Geneeskd; 1993 Jul; 137(29):1440-2. PubMed ID: 8361554
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparison of withdrawal of typical and atypical antipsychotic drugs: a case study.
    Alphs LD; Lee HS
    J Clin Psychiatry; 1991 Aug; 52(8):346-8. PubMed ID: 1869497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dystonic reaction and relapse with clozapine discontinuation and risperidone intiation.
    Dickson R; Williams R; Dalby JT
    Can J Psychiatry; 1994 Apr; 39(3):184. PubMed ID: 7518338
    [No Abstract]   [Full Text] [Related]  

  • 25. Understanding and treating psychoses: advances in research and therapy.
    J Clin Psychiatry; 1993 Nov; 54(11):445-52. PubMed ID: 7903666
    [No Abstract]   [Full Text] [Related]  

  • 26. D1-, D2-, and 5-HT2-receptor occupancy in clozapine-treated patients.
    Farde L; Nordström AL; Nyberg S; Halldin C; Sedvall G
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():67-9. PubMed ID: 7961577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment-resistant schizophrenia].
    Yahyaten OB
    Rev Med Brux; 2014; 35(3):169-73. PubMed ID: 25102584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Towards more effective antipsychotic treatment.
    Kane JM; Freeman HL
    Br J Psychiatry Suppl; 1994 Nov; (25):22-31. PubMed ID: 7865194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of long-term lithium treatment on reserpine-induced supersensitivity in dopaminergic and serotonergic transmission.
    Friedman E; Dallob A; Levine G
    Life Sci; 1979 Oct; 25(14):1263-6. PubMed ID: 229375
    [No Abstract]   [Full Text] [Related]  

  • 30. The effects of clozapine on neurocognition: an overview.
    Goldberg TE; Weinberger DR
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():88-90. PubMed ID: 7525543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The new atypical antipsychotics. A lack of extrapyramidal side-effects and new routes in schizophrenia research.
    Kerwin RW
    Br J Psychiatry; 1994 Feb; 164(2):141-8. PubMed ID: 7513599
    [No Abstract]   [Full Text] [Related]  

  • 32. Managing clozapine discontinuation - acute and chronic maintenance strategies.
    Shields MK; Bastiampillai T; Mohan T
    Aust N Z J Psychiatry; 2012 Nov; 46(11):1104-5. PubMed ID: 23104931
    [No Abstract]   [Full Text] [Related]  

  • 33. Obsessive-compulsive symptoms and clozapine.
    Dursun SM; Reveley MA
    Br J Psychiatry; 1994 Aug; 165(2):267-8. PubMed ID: 7953043
    [No Abstract]   [Full Text] [Related]  

  • 34. An overview of the mechanism of action of clozapine.
    Meltzer HY
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():47-52. PubMed ID: 7961573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dopamine and schizophrenia. A reappraisal in the light of clinical studies with clozapine.
    Nair NP; Zicherman V; Schwartz G
    Can Psychiatr Assoc J; 1977 Oct; 22(6):285-93. PubMed ID: 21741
    [No Abstract]   [Full Text] [Related]  

  • 36. Dopaminergic and serotonergic effects of clozapine. Implications for a unique clinical profile.
    Meltzer HY; Gudelsky GA
    Arzneimittelforschung; 1992 Feb; 42(2A):268-72. PubMed ID: 1586397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anticholinergics to treat clozapine withdrawal.
    de Leon J; Stanilla JK; White AO; Simpson GM
    J Clin Psychiatry; 1994 Mar; 55(3):119-20. PubMed ID: 8071251
    [No Abstract]   [Full Text] [Related]  

  • 38. Rapid release of antipsychotic drugs from dopamine D2 receptors: an explanation for low receptor occupancy and early clinical relapse upon withdrawal of clozapine or quetiapine.
    Seeman P; Tallerico T
    Am J Psychiatry; 1999 Jun; 156(6):876-84. PubMed ID: 10360126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clozapine withdrawal. A review].
    Szafrański T; Gmurkowski K
    Psychiatr Pol; 1999; 33(1):51-67. PubMed ID: 10786215
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacology of N-desmethylclozapine.
    Lameh J; Burstein ES; Taylor E; Weiner DM; Vanover KE; Bonhaus DW
    Pharmacol Ther; 2007 Aug; 115(2):223-31. PubMed ID: 17583355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.